|
||
|
| Home |  |
Firm Description | |
Sectors Covered | |
Completed Transactions | |
Testimonials | |
Principals | |
M&A Report and Publications |
|
Contact Us | |
| Acquiring Party | McKesson Corporation (NYSE:MCK), a national pharmaceutical distributor and healthcare services company. |
|---|---|
| Transferring Party | Oncology Therapeutics Network, a US distributor of specialty oncology pharmaceuticals. |
| Sector | Distribution |
| Date | October 5, 2007 |
| Analysis OTN is one of the nation's largest distributors of specialty drug products, serving > 3,500 oncologists, 1,500 rheumatologists and other providers. Distribution of specialty drugs is a growth area. Deal value - $575m on sales of - $3b (0.2x reflecting the high volume/low margin nature of the business). | |
The Walden Group is a leading healthcare investment banking firm specializing in mergers, acquisitions and strategic transactions. It also invests its own funds and, together with its expert operational partners, provides value-added services to help special companies reach critical milestones. This information is copyright © 2004-2010 The Walden Group, Inc. This information is provided as a service to the public but remains the intellectual property of The Walden Group, Inc and may not be reproduced in any manner without the written permission of The Walden Group, Inc. The information contained in the transactions table was derived from publicly available and other sources. Transaction analysis and other information are based, in part, upon public comments, Walden Group research and judgments, and reporting and research of others. The information is not intended to be relied upon as pronouncements by the transaction participants or for any other reason. | |